Align Technology

Q3 2026
Speakers

Oct 28, 2026 · 67 min

PREPARED REMARKS · INFERREDKeys: / search · Space play · ←→ ±10s · [] sections

Prepared remarks

Speaker 0

Unverified voice label

Greetings, welcome to the Aligned Third Quarter 2026 earnings call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. Please note this conference is being recorded. I will now turn the conference over to your host, Shirley Stacy, with Align Technology. You may begin.

Passages & reports (2)
  • Greetings, welcome to the Aligned Third Quarter 2026 earnings call. At this time, all part…
  • Technology. You may begin.

Speaker 1

Unverified voice label

Good afternoon, thank you for joining us. I'm Shirley Stacy, Vice President of Corporate Communications and Investor Relations. Joining me for today's call is Joe Hogan, President and CEO, and John Marici, CFO. ?We issued third quarter 2026 financial results today via BusinessWire, which is available on our website at investor.aligntech.com. Today's conference call is being audio webcast and will be archived on our website for approximately one month.

As a reminder, the information provided and discussed today will include forward looking statements, including statements about Align's future events,
product outlook, and financial expectations. These forward looking statements are only predictions and involve risks and uncertainties that are described in more detail ?in our most recent periodic reports filed with the Securities and Exchange Commission, available on our website and at sc.gov. Actual results may vary significantly, and Align expressly assumes no obligation to update any forward-looking statement.

We've posted historical financial statements with corresponding reconciliations, including our gap to non-gap reconciliation, if applicable,
and our third quarter 2026 conference call slides on our website under quarterly results. Please refer to these files for more detailed information. With that, I'd like to turn the call over to Align Technologies President and CEO, Joe Hogan. Joe.

Passages & reports (7)
  • Good afternoon, thank you for joining us. I'm Shirley Stacy, Vice President of Corporate C…
  • We
  • issued third quarter 2026 financial results today via BusinessWire, which is available on …
  • product outlook, and financial expectations. These forward looking statements are only pre…
  • in
  • our most recent periodic reports filed with the Securities and Exchange Commission, availa…
  • and our third quarter 2026 conference call slides on our website under quarterly results. …

Speaker unclear

?Thanks,

Passages & reports (1)
  • Thanks,

Speaker 2

Unverified voice label

Shirley. Good afternoon, and thanks for joining us. On today's call, I'll review our third quarter performance and the growth priorities we're executing across the line. John will then discuss our financial results and outlook for Q4 and fiscal 2026. Before we start, I'd like to note that we announced our CEO succession plan earlier today. I'll return to this topic at the end of the call.

For now, let's focus on our third quarter results.
?We delivered a solid third quarter results with record doctor submitters, record third-quarter clear liner shipments, improved utilization, and broad-based international growth. Worldwide revenue was 1.015 billion, up 1.9% year over year, or 2.4% ?at a constant currency, and in line with our outlook. Clearliner shipments increased 6.6% to 691,000 ?at the high end of our expectation for mid-single-digit growth in Q3. ?

In
systems and services, revenue was 175.5 million, down 7.6 year over year, and generally consistent with the guidance we provided at Q2. Reported revenue continues to reflect a shift toward lower price scanner configurations and more flexible acquisition models and stable ASP on a like-for-like basis, while our installed base and customer footprint continue to expand. ?From a profitability perspective, non-gap gross margin was 70.4%, modestly below our expectation, reflecting higher fuel-related transportation costs.

Lower clear liner ASP and the impact of geographic and product mix. Disciplined expense management and productivity improvements contributed to non-gap
operating profit margin of 24.4% above our outlook. Overall, QFEE demonstrated our ability to execute in a challenging environment, delivering continued clear liner growth, expanding our digital platform and consumer footprint, and improving profitability. We remain focused on continuing to drive growth and building on this progress across several key areas.

We continue to drive adoption and utilization across customer channels. That includes increasing utilization among orthodontists, expanding Invisalign adoption among GP dentists, and growing with DSOs and strategic accounts. During Q3, a record
91,000 doctors submitted Invisalign cases, up more than 3% year over year, while overall utilization increased 3.4%. We are expanding ?the patients and clinical needs that we address. Younger patients remain one of our largest growth opportunities and were again an important contributor to our Q3 performance.

Younger patient shipments increased at a double-digit rate in international markets with strong teen performance across APAC and EMEA. Our growing patient portfolio, including Invisalign First, Invisalign
Palate Expander, and Manuel Burr Advancement with Occlusal Blocks, enables doctors to address younger and more complex patients while expanding the range of orthodontic needs that can be addressed with invisalign treatment. Affordability and patient conversion continue to be important focus for ?us.

Our zero additional liner offering, providing doctors with a greater treatment and pricing flexibility.

Passages & reports (21)
  • Shirley. Good afternoon, and thanks for joining us. On today's call, I'll review our third…
  • today. I'll return to this topic at the end of the call. For now, let's focus on our third…
  • We
  • delivered a solid third quarter results with record doctor submitters, record third-quarte…
  • at
  • a constant currency, and in line with our outlook. Clearliner shipments increased 6.6% to …
  • at
  • the high end of our expectation for mid-single-digit growth in Q3.
  • In
  • systems and services, revenue was 175.5 million, down 7.6 year over year, and generally co…
  • installed base and customer footprint continue to expand.
  • From
  • a profitability perspective, non-gap gross margin was 70.4%, modestly below our expectatio…
  • operating profit margin of 24.4% above our outlook. Overall, QFEE demonstrated our ability…
  • building on this progress across several key areas. We continue to drive adoption and util…
  • 91,000 doctors submitted Invisalign cases, up more than 3% year over year, while overall u…
  • the
  • patients and clinical needs that we address. Younger patients remain one of our largest gr…
  • Palate Expander, and Manuel Burr Advancement with Occlusal Blocks, enables doctors to addr…
  • us.
  • Our zero additional liner offering, providing doctors with a greater treatment and pricing…

Speaker 2

Q3. We're also continuing to expand the value of the Align Digital Platform. The opportunity goes beyond clear aligners or scanner placements individually. ?We are connecting ITERO, scanning diagnostics, AI enabled treatment planning, Invisalign treatment, EXOCAD restorative workflows, and practice applications to create a more integrated digital workflow for doctors and patients. This also represents a growth opportunity beyond traditional orthodontics. Through dental laboratories, we can reach GP dentists more broadly and enable digital workflows that integrate tooth movement with restorative treatment and planning.

Invisalign advanced restorative treatment, or ART, as we refer to, is a compelling example of a line expanding its role in comprehensive dentistry, creating new clinical use cases, strengthening
ecosystem connectivity, ?and increasing our long-term opportunity across the broader dental marketplace. Importantly, this approach also aligns with the growing focus on oral health by helping clinicians plan treatment more holistically, recognizing the relationship between tooth position, function, restorative outcomes, and long-term patient ?care.

These growth opportunities reinforce one another, expanding our doctor customer base, increasing utilization, addressing more patients and clinical needs, improving affordability and conversion,
?and deepening adoption of our digital platform. So together they give us multiple pathways to drive growth across the line. With that context, let me turn to our regional performance and the commercial priorities we're executing to drive growth. In the Americas, clear liner shipments increased approximately 1.5% year over year, reflecting different performance trends across North America and Latin America.

For the first time in six quarters, North America total orthodontist shipments increased year over year, supported by growth from DSOs. North American DSO shipments increased a double digit rate overall, including growth across both orthodontist and GP customers. While the broader retail channel
remains pressured, particularly for GP customers, orthodonist retail shipments improved sequentially in Q3, with teen orthodonist retail shipments also increasing year over year.

We view the return to the year-over-year orthodonis case growth, strong DSO performance, and sequential improvements
?in orthodontic retail as an encouraging indicator, particularly given continued consumer softness. These early signs of improvement in North America reflect our focus on what we can control, strengthening commercial execution, sharpening our go-to-market strategies, and deepening key partnerships to help drive conversion. Through sustained efforts to further this progress, we believe we can we will return North America back to growth.

Our collaboration with HFD, Healthcare Finance Direct, integrates patient financing options into the Invisline workflow to give patients greater payment flexibility
?and reduce administrative function for practices. We're seeing encouraging early traction with these offerings ?and are evaluating additional financing opportunities, including our new care credit pilot. Patient interest in Invisalign remains strong, but affordability can be a barrier to starting treatment. These initiatives are part of our broader effort to address that barrier and convert more patient interest into treatment starts rather than waiting for consumer environment to improve.

During the quarter, we launched the Shift Happens campaign to consumers to increase adult consumer awareness and invisalign consideration. Our commercial focus is on helping practices convert that interest into consultation and treatment sorts.
?In Latin America, clearliner growth remained strong across channels, was up double digits year over year. DSO shipments increased significantly year over year, while retail also grew, including positive performance across both GP dentists and orthodontists.

Our Latin American priorities are centered on affordability and digital adoption, including expanding
DSP availability, advancing invisalign pay initiatives, and broadening ITRO, access through additional partners, financing alternatives, and scanner configurations. Turning to EMEA, clear liner shipments increased a double digit growth rate year over year, supported by strong utilization across orthodontist and GP Dentist ?and double digit DSO growth. Retail was also an important contributor.

AMEA retail shipments increased 8% year over year, with growth across both orthodontist and GP dentist customers. In EMEA, we are focused on orthodontist utilization, teen and growing patient treatment and clinical education,
especially class two. We're working to expand the GP engagement through digital workflows and broader treatment opportunities, including art. With DSOs, we continue to focus on improving conversion and scale adoption across practice locations.

And systems and services are focuses on expanding Illumina PC, targeting competitive and
legacy ITERO scanner users and expanding submitters through ART and third-party partnerships. In APAC, clearliner shipments are up double-digit sequentially and increased year over year, driven by record doctor submitters and strong younger patient demand. Team shipments increased double-digits year over year led by China.

Passages & reports (28)
  • Q3. We're also continuing to expand the value of the Align Digital Platform. The opportuni…
  • We
  • are connecting ITERO, scanning diagnostics, AI enabled treatment planning, Invisalign trea…
  • GP dentists more broadly and enable digital workflows that integrate tooth movement with r…
  • ecosystem connectivity,
  • and
  • increasing our long-term opportunity across the broader dental marketplace. Importantly, t…
  • care.
  • These growth opportunities reinforce one another, expanding our doctor customer base, incr…
  • and
  • deepening adoption of our digital platform. So together they give us multiple pathways to …
  • North America and Latin America. For the first time in six quarters, North America total o…
  • remains pressured, particularly for GP customers, orthodonist retail shipments improved se…
  • in
  • orthodontic retail as an encouraging indicator, particularly given continued consumer soft…
  • further this progress, we believe we can we will return North America back to growth. Our …
  • and
  • reduce administrative function for practices. We're seeing encouraging early traction with…
  • and
  • are evaluating additional financing opportunities, including our new care credit pilot. Pa…
  • During the quarter, we launched the Shift Happens campaign to consumers to increase adult …
  • In
  • Latin America, clearliner growth remained strong across channels, was up double digits yea…
  • DSP availability, advancing invisalign pay initiatives, and broadening ITRO, access throug…
  • and
  • double digit DSO growth. Retail was also an important contributor. AMEA retail shipments i…
  • especially class two. We're working to expand the GP engagement through digital workflows …
  • legacy ITERO scanner users and expanding submitters through ART and third-party partnershi…

Retail was the primary channel growth driver in APAC during Q3. APAC retail shipments increased 16% year over year, with double-digit growth across both Orthodontist and GP Dentist customers. In APAC, we are focused on expanding adoption, improving conversion, and strengthening the customer experience. This includes expanding private distributor coverage in China, increasing penetration in lower tier cities, and activating DSOs and accelerating tween and teen treatment.

We're also focused on improving patient conversion in Japan
?through orthodontist growth programs as well as driving ITERO initiatives. Across the rest of Asia, our focus is on building on the momentum and higher growth markets, including India, Korea, and Taiwan. Customer experience is also an important growth lever across APAC. We're focused on clinical support, customer service, simplifying commercial processes, and improving the digital experience.

Together, these actions give us multiple avenues to expand growth across orthodontists, GP dentists, retail practices, DSOs, younger patients, and digital workflows. We continue to see a significant opportunity to expand the Invisline adoption among GP dentists by connecting orthodontic treatment more closely with restorative and
broader oral healthcare workflows. GP performance remains variable by market and channel. North America GP retail remains pressured, while AMEA and APAC GP retail both delivered positive year-over-year growth, and North America GP DSO grew double digits.

These results reinforce our view that
GP adoption can expand through clinical education, affordability, digital workflows, and broader restorative treatment opportunities. Art is one example of how we are connecting alignment and restorative treatment planning. Along with ITERO, ExOCAD, and our broader digital platform, these workflows help us engage GP dentists across a wider range of treatment options and create new opportunities to incorporate Invisalign into restorative patient care.

Turning to systems and services, Q3 revenue was $175.5 million, down 7.6% year over year.
?The difference between reported revenue and underlying adoption remains important. This reflects a deliberate strategic shift toward flexible acquisition models rather than weakening demand. Revenue continues to reflect ?a greater mix of lower price configurations as well as flexible acquisition models, including leasing, financing, rentals, and certified pre-owned systems. ?The mix of ITERO leased units continues to grow ?and was up double digits again year over year.

These customer-focused solutions are designed to lower the initial barrier to adoption, expand our customer footprint, and give doctors more ways to access our digital technology. Our focus remains on expanding ITERO's reach, and in Q3, the number of scanner units placed, including leased,
rented, and certified pre-owned systems, increased double-digit year over year to more than 157,000 systems globally. ?In limited pilot, 11 DSO location practices integrating ITERO Lumina within VisLine Practice App increased new patient exam capacity by approximately 15% without adding staff or extending operating hours.

Nearly three-quarters of participating locations improve productivity. The long-term value of systems and services
extends beyond the initial scanner placement. ?A larger, more engaged, and trained installed base creates opportunities to expand adoption of restorative workflows and generate recurring software and services revenue. Before turning the call over to John, I want to briefly update you on our strategic initiatives we discussed last quarter. Following our constructive and ongoing discussions with Elliott Management, the first of our three independent directors joined Align Board in August.

Quentin Blackford, president and CEO of iRhythm Technologies, is an accomplished global healthcare and medtech leader, and we're pleased to welcome him to Align. Our strategic and operating model review is progressing with work focused on commercial effectiveness,
organizational scalability, operating efficiency, and resource allocation. We're particularly focused on ways to improve performance of North America and identifying additional margin expansion opportunities without compromising growth.

We are incorporating early observations into our planning and operating process,
?and we'll provide additional detail as objectives are finalized and we can quantify their expected impact. The operating improvements we are already delivering also reflect broader work across manufacturing, productivity, automation, treatment efficiency, and disciplined resource allocation. Our goal is straightforward, drive profitable growth while building a more efficient and scalable business. With that, I'll turn the call over to John.

Thank you, Joe. Before turning to our results, I'd
?like to express my sincere gratitude

Passages & reports (29)
  • Retail was the primary channel growth driver in APAC during Q3. APAC retail shipments incr…
  • This includes expanding private distributor coverage in China, increasing penetration in l…
  • through
  • orthodontist growth programs as well as driving ITERO initiatives. Across the rest of Asia…
  • the digital experience. Together, these actions give us multiple avenues to expand growth …
  • broader oral healthcare workflows. GP performance remains variable by market and channel. …
  • GP adoption can expand through clinical education, affordability, digital workflows, and b…
  • across a wider range of treatment options and create new opportunities to incorporate Invi…
  • The
  • difference between reported revenue and underlying adoption remains important. This reflec…
  • a
  • greater mix of lower price configurations as well as flexible acquisition models, includin…
  • The
  • mix of ITERO leased units continues to grow
  • and
  • was up double digits again year over year. These customer-focused solutions are designed t…
  • rented, and certified pre-owned systems, increased double-digit year over year to more tha…
  • In
  • limited pilot, 11 DSO location practices integrating ITERO Lumina within VisLine Practice …
  • extends beyond the initial scanner placement.
  • A
  • larger, more engaged, and trained installed base creates opportunities to expand adoption …
  • Management, the first of our three independent directors joined Align Board in August. Que…
  • organizational scalability, operating efficiency, and resource allocation. We're particula…
  • and
  • we'll provide additional detail as objectives are finalized and we can quantify their expe…
  • and scalable business. With that, I'll turn the call over to John. Thank you, Joe. Before …
  • like
  • to express my sincere gratitude

Speaker unclear

?for your leadership and

Passages & reports (1)
  • for your leadership and

Speaker 3

Unverified voice label

partnership over the years,

Passages & reports (1)
  • partnership over the years,

Speaker unclear

?as well as your many

Passages & reports (1)
  • as well as your many

Speaker 3

contributions to Align. Your impact will continue to benefit the company and help

Passages & reports (1)
  • contributions to Align. Your impact will continue to benefit the company and help

Speaker 2

shape our future

Passages & reports (1)
  • shape our future

Speaker 3

success.

Passages & reports (1)
  • success.

Speaker 2

Total revenues for the

Passages & reports (1)
  • Total revenues for the

Speaker unclear

?third quarter

Passages & reports (1)
  • third quarter

Speaker 3

were

Passages & reports (1)
  • were

Speaker 2

$1 billion, 14.8 million dollars, up ?one point nine percent year over year and in line with our Q three expectations. On a constant currency basis, total revenue was two point four percent year over year. Q3 clear aligner revenue was eight hundred and thirty nine point three million dollars up four point two percent year over year, primarily reflecting higher volume price increases, lower net deferrals, and higher non-case revenue, partially offset by geographic and product mix, higher discounts, and unfavorable foreign exchange.

On a constant currency basis,

Passages & reports (4)
  • $1 billion, 14.8 million dollars, up
  • one
  • point nine percent year over year and in line with our Q three expectations. On a constant…
  • price increases, lower net deferrals, and higher non-case revenue, partially offset by geo…

Speaker 3

Q326

Passages & reports (1)
  • Q326

Speaker 2

clear aligner revenue was up 4.7% year over year. Clear aligner revenue per case shipment was $1,215, down 2.3% year over year or 1.8% at constant currency, consistent with our expectation, primarily due to mixed shift to lower price countries and products and higher discounts, partially offset by price increases and lower net deferrals. Q3 systems and services revenue was $175.5 million, down 7.6% year over year.

Revenue continued to reflect the mix towards lower

Passages & reports (2)
  • clear aligner revenue was up 4.7% year over year. Clear aligner revenue per case shipment …
  • and higher discounts, partially offset by price increases and lower net deferrals. Q3 syst…

Speaker 3

price scanners

Passages & reports (1)
  • price scanners

Speaker unclear

?and flexible

Passages & reports (1)
  • and flexible

Speaker 2

acquisition models. On

Passages & reports (1)
  • acquisition models. On

Speaker 3

a constant currency basis, systems

Passages & reports (1)
  • a constant currency basis, systems

Speaker 2

and services ?revenue was down 7.1% year over year.

Passages & reports (3)
  • and services
  • revenue
  • was down 7.1% year over year.

Speaker 3

Importantly, like-for-like scanner pricing stabilized during the quarter.

Passages & reports (1)
  • Importantly, like-for-like scanner pricing stabilized during the quarter.

Speaker 2

Moving on to gross margin. Third quarter overall gross margin was 68.7%, up approximately 4.5 percentage points year over year, or 5.3 percentage points at constant currency. Performance primarily reflected operational efficiencies and the absence of significant prior year charges, partially offset by lower ASP, restructuring and other charges, and unfavorable foreign exchange. Importantly, the lower ASP is primarily due to product and geographic mix rather than change in pricing discipline. ?

On
a non-gap basis, Q3 gross margin was 70.4%, flat year over year, and approximately 0.7 percentage points higher at constant currency, but modestly below our outlook of approximately

Passages & reports (4)
  • Moving on to gross margin. Third quarter overall gross margin was 68.7%, up approximately …
  • prior year charges, partially offset by lower ASP, restructuring and other charges, and un…
  • On
  • a non-gap basis, Q3 gross margin was 70.4%, flat year over year, and approximately 0.7 per…

Speaker unclear

?71%.

Passages & reports (1)
  • 71%.

Speaker 3

The variance primarily reflected lower clearliner ASV, product and geographic mix, and systems and services mix, partially offset by manufacturing productivity, automation, and lower refinement rates. Q3 clear liner gross margin was 69.3%, up approximately 4.4 percentage points year by year, primarily reflecting operational efficiencies and lower depreciation expense on assets disposed of other than by sale, partially offset by elevated freight costs, restructuring costs, and lower ASP. ?

On
a constant currency basis, Q3 clear liner gross margin was up five point two percentage points year over year. ?Q three systems and services gross margin was sixty six point two percent, up approximately four point nine percentage points year over year, primarily due to lower restructuring, cogs deficiencies, and lower US tariff rates, partially offset by lower ASP. On a constant currency basis, Q three systems and services gross margin was up five point five percentage points year over year.

Third quarter operating income was one hundred and sixty nine point two million dollars, resulting in an operating margin of 16.7%, up approximately 7% points year over year, or 8.5 percentage points at constant
currency. ?On a non-gap basis, Q3 operating margin was 24.4%, up approximately 0.5 percentage points year over year, and approximately 1.4 percentage points at constant currency. Disciplined expense management and continued productivity improvements allowed us to exceed our non-gap operating margin expectation despite the modest gross margin shortfall.

Our Q three gap effective tax rate was twenty point six percent compared with forty point one percent in the third quarter of twenty twenty-five, primarily primarily reflecting the prior year impact of restructuring charges in our jurisdictional
mix of income and lower U.S. taxes on foreign earnings in the current quarter. ?Our Q three non GAAP effective tax rate was twenty percent. Third quarter diluted net income per share was $1.90, up $1.12 compared to the prior year. ?

On
a non-GAAP basis, Q3 diluted net income per share was $2.80, up 7.3% year over year. GAP and non-GAP EPS were unfavorably, were each unfavorably impacted by approximately 24 cents year over year from foreign exchange. As of September 30th, cash and cash equivalents totaled $1,145 million, up approximately $140 million year over year. Cash flow from operations was $183.2 million. Capital expenditures were $45.1 million, and free cash flow was approximately $138 million, during Q3, we repurchased approximately $627,000 shares in an average price of $164.73 per share,

Passages & reports (18)
  • The variance primarily reflected lower clearliner ASV, product and geographic mix, and sys…
  • percentage points year by year, primarily reflecting operational efficiencies and lower de…
  • On
  • a constant currency basis, Q3 clear liner gross margin was up five point two percentage po…
  • Q
  • three systems and services gross margin was sixty six point two percent, up approximately …
  • up five point five percentage points year over year. Third quarter operating income was on…
  • currency.
  • On
  • a non-gap basis, Q3 operating margin was 24.4%, up approximately 0.5 percentage points yea…
  • margin expectation despite the modest gross margin shortfall. Our Q three gap effective ta…
  • mix of income and lower U.S. taxes on foreign earnings in the current quarter.
  • Our
  • Q three non GAAP effective tax rate was twenty percent. Third quarter diluted net income p…
  • On
  • a non-GAAP basis, Q3 diluted net income per share was $2.80, up 7.3% year over year. GAP a…
  • 30th, cash and cash equivalents totaled $1,145 million, up approximately $140 million year…
  • approximately $138 million, during Q3, we repurchased approximately $627,000 shares in an …

Speaker 3

Year to date, we have repurchased $200 million of common stock. For fiscal 2026, we expect to repurchase approximately $500 million of common stock, up from $466 million repurchased in 2025, and reflecting the conviction of our board and management in aligns long-term value. ?Now turning to Q4 and fiscal 2026, I am pleased to deliver third quarter revenue and clearer liner volume in line with our outlook while improving year over year profitability.

Consistent with our first and second quarters, these results were achieved against a challenging market backdrop. As demand across the dental
and orthodontic industry continued to be affected by a softer environment for discretionary health care spending and capital equipment investment. Those conditions persisted through the third quarter, and our fourth quarter outlook reflects what we continue to see across the broader market. Our updated 2026 guidance reflects a reduction in expected reported revenue versus our prior outlook provided at Q2, driven by two main factors.

First, our Q4 systems and services revenues outlook is lower than our prior guidance. Although we expect scanner volume, expect scanner volume growth and saw scanner
ASP stabilize on a like-for-like basis during Q3, product mix continues to shift towards lower price scanners and more flexible acquisition models, which resonates well with customers amid a more challenging environment for capital equipment purchases. Second, we have slightly lowered our clear aligner volume as well as ASP assumption, largely driven by product and geographic mix, in addition to foreign exchange.

Assuming no circumstances occur beyond our control that could impact our business. For Q4 2026, we expect worldwide revenues to be in the
range of one billion dollars to one billion and twenty million dollars. We expect Q4 clear aligner volume to be up low single digits year over year. We expect clear aligner ASP to be down approximately one percent year over year. We expect systems and services revenue to be in the range of one hundred and seventy to one hundred and eighty million dollars.

We expect worldwide gap gross margin to be approximately 71%, and non-GAAP gross margin to be approximately 72%.
?We expect GAAP operating margin to be approximately 20%. We expect non-gap operating margin to be approximately 26%. For Q4 2026, we expect to reach repurchase up to $300 million of our common stocks. For fiscal 2026, we expect 2026 worldwide revenue to be approximately $4.11 billion to $4.13 billion.

We continue to expect 2026 Clear Aligner volume and revenue growth to be up approximately 5 to 6% year over year. We expect
2026 Clear Aligner ASB to be slightly below 2025. We expect 2026 systems and services revenue to be $715 to $725 million. We expect 2026 GAAP operating margin to be approximately 16.2%, up approximately 2.7 points year over year. We expect 2026 non-gap operating margin of approximately 23.7%, representing approximately 100 basis point improvement year over year, consistent with our previous guidance.

We expect capital expenditures of approximately
125 to $150 million. We expect to repurchase approximately $500 million of our common stock during 2026. As we look to 2027, we believe we are well positioned to deliver another year of revenue growth and margin expansion. Importantly, our preliminary planning assumes an operating environment broadly consistent with current conditions and does not require a consumer recovery. We expect to continued driving in invisalign volume growth in 2027.

Record doctor submitters, improving utilization, and the growth
initiatives discussed today support that confidence with additional initiatives under development. We also continue to expect a broadly stable, clear line of pricing environment with ASB slightly down, driven primarily by product and geographic mix. For systems and services, 2026 has been a transition year for revenue. We expect solid unit growth and continued expansion of our installed base, and we expect stable ASBs positioning systems and services for revenue growth in 2027.

On profitability, we continue to target at least another 100 basis points of non-gap
operating margin improvement in 2027, building on the approximately 100 basis points we expect to deliver in 2026. Our focus is on improving efficiency while preserving investment in the initiatives that support sustainable revenue growth. Share repurchases should provide an additional benefit to earnings for share growth as we continue to view buybacks as an attractive use of capital at prices that we do not believe reflect along a line's long-term value creation potential.

We will provide our full 2027 outlook when we report fourth
quarter results following the completion completion of our strategic and operating model review with Jen leading the business. With that, I'll turn it back to Joe. Joe?

Passages & reports (22)
  • Year to date, we have repurchased $200 million of common stock. For fiscal 2026, we expect…
  • long-term value.
  • Now
  • turning to Q4 and fiscal 2026, I am pleased to deliver third quarter revenue and clearer l…
  • and orthodontic industry continued to be affected by a softer environment for discretionar…
  • reduction in expected reported revenue versus our prior outlook provided at Q2, driven by …
  • ASP stabilize on a like-for-like basis during Q3, product mix continues to shift towards l…
  • aligner volume as well as ASP assumption, largely driven by product and geographic mix, in…
  • range of one billion dollars to one billion and twenty million dollars. We expect Q4 clear…
  • of one hundred and seventy to one hundred and eighty million dollars. We expect worldwide …
  • We
  • expect GAAP operating margin to be approximately 20%. We expect non-gap operating margin t…
  • 2026 worldwide revenue to be approximately $4.11 billion to $4.13 billion. We continue to …
  • 2026 Clear Aligner ASB to be slightly below 2025. We expect 2026 systems and services reve…
  • up approximately 2.7 points year over year. We expect 2026 non-gap operating margin of app…
  • 125 to $150 million. We expect to repurchase approximately $500 million of our common stoc…
  • preliminary planning assumes an operating environment broadly consistent with current cond…
  • initiatives discussed today support that confidence with additional initiatives under deve…
  • has been a transition year for revenue. We expect solid unit growth and continued expansio…
  • operating margin improvement in 2027, building on the approximately 100 basis points we ex…
  • additional benefit to earnings for share growth as we continue to view buybacks as an attr…
  • quarter results following the completion completion of our strategic and operating model r…

Speaker unclear

?Let

Passages & reports (1)
  • Let

Speaker 2

me close by bringing together what you've heard today. We delivered solid Q3 performance with record third-quarter clear liner shipments, record doctor submitters, improved utilization, continued expansion of our tarot customer footprint, and stronger operating performance, varied by market and channel. But we also saw important areas of traction, including overall orthodontist growth, strong DSO performance in Latin America, broad-based growth in EMEA, and strong retail performance in APAC and America.

While the external environment remains challenging, our results continue to demonstrate that we have meaningful opportunities to improve performance through execution, regardless of the pace of the macroeconomic recovery. We're
focusing on increasing utilization among orthodontists, expanding in Bizline adoption among GP dentists, growing with DSOs and strategic accounts, extending our leadership in kids and teens, improving affordability and patient conversion, and increasing adoption of our digital workflows.

Across systems and services, our priorities are to expand the
ITERO customer footprint, increase utilization, and connect scanning more deeply with diagnostics, treatment planning, restorative workflows, ?and invisalign treatment across the aligned digital platform. We also have a significant innovation pipeline ahead of ?us. Across digital treatment planning, AI-enabled capabilities, growing patient treatment, restorative workflows, scanning solutions, and CADCAN software, we're investing in technologies that can expand clinical applicability, improve the customer experience, and make our business more productive at scale.

We continue to be excited about our next
generation Direct Fabrication 3D printed materials platform, what we call NXT technology. NXT unlocks greater control, consistency, and precision across appliance. It designs enables an entirely new level of Invisalign performance and personalization. Building on the Invisline Palette Expander, our first direct 3D printed orthodontic appliance, we are broadening the application of 3D printing across the Invisline portfolio as well as expanding it into new categories.

Invisalign specifics attachment systems launched this year expands our 3D printing capabilities beyond aligners and appliances into attachment system itself. By
connecting digital treatment planning, manufacturing, clinical delivery, it represents another step toward a fully integrated digital workflow. This week we will begin a U.S. pilot of a new product category, sports mouth guards, powered by our 3D printing technology and material science capabilities. Sports mouth guards represent a large and growing market opportunity and then growing awareness of concussion risk and contact sports.

There's also significant overlap with kids and teens, as we expect it to drive awareness and utilization of Invisalign treatment through Invisalign doctors while providing incremental revenues.
?The Invisalign Sports Guard is is a custom direct 3D printed sports mouth guard made from an Itero digital scan. It comes in multiple thickness options and will be available through participating Invisalign providers. Invisalign Sports Guards are customizable for each athlete's unique needs for comfort and sport.

Optimized for high performance,
specific to the activity, thanks to the power of high performance polymers and unique 3D printed designs. Expected to offer over time a broader set of diagnostics and other sensing capabilities. These are important steps in a broader roadmap that includes additional orthodontic applications and the opportunity to apply direct fabrication technology more broadly to aligner treatment. We will continue to advance the roadmap as we scale the technology and validate each application. ?

What
gives me confidence looking ahead is that we are not dependent on any single growth driver, geography or customer segment. We have opportunities to increase orthodontist utilization, expand GP adoption, grow with DSOs, extend our leadership in kids and teens, improve affordability and patient conversion, and increase adoption of the Aligned Digital Platform. Before we open the calls for questions, I want to briefly address my decision to step down ?and the planned CEO succession announcement we made today.

Leading aligned has been a tremendous privilege, and this is an amazing decision, a meaningful and amazing decision for me as we move forward. The process has been carefully planned for some time
?and reflects a thoughtful long term focus. As announced, our board has appointed Jennifer Davis as Alliance next CEO. Jen will join us on November 2nd as CEO elect and a member of our board.

She will assume the CEO and president role on December 31st of this year. Jen brings 33 years of leadership experience,
including leading Procter Gamble's global healthcare business, with global experience across innovation, digital transformation, brand building operations, and customer development and oral health. Jen will be joining the company with a powerful innovation platform, a talented global team, trusted relationship with doctors around the world, and significant opportunities across orthodontics and digital dentistry.

I'm extremely proud of the line, the strong foundation we've established, and the relentless contributions of every member of our board, management team, and organization. I am confident in this transition plan and I'm looking forward to working closely with Jen over the coming months. I strongly believe she
is the right leader to build on that foundation and lead a line through the next phase of growth and value creation. ?

My
focus remains squarely on driving the business, executing the priorities we discussed today, and continuing to advance the growth, innovation, and operating initiatives underway across the line. I remain confident in the opportunities ahead for a line, in the team executing our strategy, and in our ability to continue to build long term value for our customers, shareholders, and employees. Thank you for joining

Passages & reports (29)
  • me close by bringing together what you've heard today. We delivered solid Q3 performance w…
  • overall orthodontist growth, strong DSO performance in Latin America, broad-based growth i…
  • focusing on increasing utilization among orthodontists, expanding in Bizline adoption amon…
  • ITERO customer footprint, increase utilization, and connect scanning more deeply with diag…
  • and
  • invisalign treatment across the aligned digital platform. We also have a significant innov…
  • us.
  • Across digital treatment planning, AI-enabled capabilities, growing patient treatment, res…
  • generation Direct Fabrication 3D printed materials platform, what we call NXT technology. …
  • first direct 3D printed orthodontic appliance, we are broadening the application of 3D pri…
  • connecting digital treatment planning, manufacturing, clinical delivery, it represents ano…
  • growing market opportunity and then growing awareness of concussion risk and contact sport…
  • The
  • Invisalign Sports Guard is is a custom direct 3D printed sports mouth guard made from an I…
  • specific to the activity, thanks to the power of high performance polymers and unique 3D p…
  • fabrication technology more broadly to aligner treatment. We will continue to advance the …
  • What
  • gives me confidence looking ahead is that we are not dependent on any single growth driver…
  • adoption of the Aligned Digital Platform. Before we open the calls for questions, I want t…
  • and
  • the planned CEO succession announcement we made today. Leading aligned has been a tremendo…
  • and
  • reflects a thoughtful long term focus. As announced, our board has appointed Jennifer Davi…
  • including leading Procter Gamble's global healthcare business, with global experience acro…
  • opportunities across orthodontics and digital dentistry. I'm extremely proud of the line, …
  • is the right leader to build on that foundation and lead a line through the next phase of …
  • My
  • focus remains squarely on driving the business, executing the priorities we discussed toda…
  • our customers, shareholders, and employees. Thank you for joining

Speaker unclear

?us.

Passages & reports (1)
  • us.

Questions & answers

Speaker 2

Operator, we'll now open for questions.

Passages & reports (1)
  • Operator, we'll now open for questions.

Speaker 0

Thank you. At this time we'll be conducting a question and answer session. If you would like to ask a question, please press star one one on your telephone keypad. A confirmation tone will indicate your line is in the question queue. You may press star one one again if you would like to remove your question from the queue. For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star keys.

One moment, please, while we pull for questions.

Passages & reports (2)
  • Thank you. At this time we'll be conducting a question and answer session. If you would li…
  • your question from the queue. For participants using speaker equipment, it may be necessar…

Speaker unclear

?And

Passages & reports (1)
  • And

Speaker 0

our first question comes from Michael Troney with Learing Partners. He may proceed.

Passages & reports (1)
  • our first question comes from Michael Troney with Learing Partners. He may proceed.

Speaker 2

Afternoon.

Passages & reports (1)
  • Afternoon.

Speaker 4

Unverified voice label

Hey everyone. Thanks for taking the question. Joe, best of luck in retirement as you move on. I'll just ask one now, I'm sure there's plenty of others, but as you think about the changing conditions that you saw underlying the difference in views, in particular on case starts between what you saw in 3 Q versus what you saw in 4Q, can you give us a sense on what some of the factors were relative to the low single digit case start expectations, ?what are you seeing from a leading indicator perspective?

Anything else you can point to
?in terms of the drivers and the build on the four Q numbers? The three Q level was very strong across the board. Curious what you're seeing relative to how the setup is for four Q though as you look to uh into next year. Thank

Passages & reports (6)
  • Hey everyone. Thanks for taking the question. Joe, best of luck in retirement as you move …
  • Q versus what you saw in 4Q, can you give us a sense on what some of the factors were rela…
  • what
  • are you seeing from a leading indicator perspective? Anything else you can point to
  • in
  • terms of the drivers and the build on the four Q numbers? The three Q level was very stron…

Speaker unclear

?you. Yeah,

Passages & reports (1)
  • you. Yeah,

Speaker 2

thanks, Michael. Uh we felt great about our third quarter performance. Uh we see a challenged market really across the globe in so many countries. And as I mentioned in the script, and John mentioned his script too, we felt really good about being able to deliver in that kind of environment. As we look at the fourth quarter, we see continued challenge consumer overall.

And that's a common thing we see across the board.
?I mean, obviously, with our systems and services business, we have a reorientation that you know you saw in the third quarter and you've seen this year, and that's reflected in our go forward statement too. So this is this is not a singular type of variable that we're discussing here. This is a you know a broad based, uh, I think reticent consumer that we sense not just in North America but different parts of the world, and that's being reflected in our guidance.

Passages & reports (5)
  • thanks, Michael. Uh we felt great about our third quarter performance. Uh we see a challen…
  • at the fourth quarter, we see continued challenge consumer overall. And that's a common th…
  • I
  • mean, obviously, with our systems and services business, we have a reorientation that you …
  • a broad based, uh, I think reticent consumer that we sense not just in North America but d…

Speaker 0

Thank

Passages & reports (1)
  • Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker unclear

?Our

Passages & reports (1)
  • Our

Speaker 0

next question comes from John Block with Stiefel. He may proceed.

Passages & reports (1)
  • next question comes from John Block with Stiefel. He may proceed.

Speaker unclear

?Thanks, guys. Joe, I'll start with a question that's

Passages & reports (1)
  • Thanks, guys. Joe, I'll start with a question that's

Speaker 5

Unverified voice label

that's likely for you and probably Jennifer as well. The sports mouth guard, you know, I know it's a bit early, but more importantly, just big picture. What does it say about a line? Like, is this the start of going into adjacencies? You called out mouth guards before, even when you first got there, we heard about sleep apnea. Is this a clear liner company going forward?

Is this a 3D printing company going forward? Just love your thoughts

Passages & reports (2)
  • that's likely for you and probably Jennifer as well. The sports mouth guard, you know, I k…
  • we heard about sleep apnea. Is this a clear liner company going forward? Is this a 3D prin…

Speaker unclear

?there. Hey,

Passages & reports (1)
  • there. Hey,

Speaker 2

John, great question. Um, look, when I started, obviously sleep apnea was on the table when I shot that because I felt that technology was diversionary. I thought it was a channel we didn't understand overall. ?Uh a reimbursement system we had not a prayer of understanding and being able to sell in front of a customer. And it was an uh it was also an item that is very difficult to be able to manufacture and do ?it uh in its scale like we have to do.

And so I just thought it was a diversion in the sense of what the company would focus on.
?As I look at mouth guards, John, I can tell you that ever almost every orthodontist we have out there is asking for mouth guards. They feel that's a leader leader product for them in that team market, especially with schools and and different, you know, kind of demand profiles with schools and kids in those specific zip codes.

The reason I wanted I thought it was time to do this is we have a a a unique resin we've developed that's uh has significant advantages over resins that are used for mouth guards today. It's 3D printed.
?So these are the fourth m first mouth guard that you can make specifically for certain sports, uh certain configurations in the way people speak and how they present themselves, it gives you a huge amount of flexibility in a sense of how you can go after that marketplace.

Sports mouth guard business is anywhere between
six to eight billion dollars in how you look at it. It's primarily a boil and bite kind of a marketplace and means non-exact kind of manufacturing science that's used around it. So so John, why in this case, unique technology, very unique from a consumer standpoint, right in line with our channels of distribution.

Passages & reports (11)
  • John, great question. Um, look, when I started, obviously sleep apnea was on the table whe…
  • Uh
  • a reimbursement system we had not a prayer of understanding and being able to sell in fron…
  • it
  • uh in its scale like we have to do. And so I just thought it was a diversion in the sense …
  • As
  • I look at mouth guards, John, I can tell you that ever almost every orthodontist we have o…
  • specific zip codes. The reason I wanted I thought it was time to do this is we have a a a …
  • So
  • these are the fourth m first mouth guard that you can make specifically for certain sports…
  • six to eight billion dollars in how you look at it. It's primarily a boil and bite kind of…

Our orthos want to have it, GPs want it too, but orthos also so we can sell it through our current channels without any kind of friction. So I look at it as 180 degrees versus sleep apnea devices.

Passages & reports (1)
  • Our orthos want to have it, GPs want it too, but orthos also so we can sell it through our…

Speaker 5

Great colour. Thank you. And then as the follow-up, you know, John, for the quarterly case is better, I think certainly better and better than feared. ASP light, maybe you can give a little bit more on that dynamic because ?if I'm thinking about this correctly, Comp no AA is not an upfront ASP hit, arguably. And then maybe you could just also touch on the exit rate.

I know most of the revisions for 4Q were a lot are were around systems and services and maybe a little FX,
?but it it does seem like you noodled down clear line a a bit. So maybe you can just talk about that exit rate there. Thanks, guys.

Passages & reports (5)
  • Great colour. Thank you. And then as the follow-up, you know, John, for the quarterly case…
  • if
  • I'm thinking about this correctly, Comp no AA is not an upfront ASP hit, arguably. And the…
  • but
  • it it does seem like you noodled down clear line a a bit. So maybe you can just talk about…

Speaker 3

Yeah yeah thanks John. I'll start with ASP. Yes. ASPs were about what we expected. We had a little bit unfavorable FX. We get the continued country and product mix. So two of the reasons driving some of that ASP um kind of sequentially down really the growth that you see in many of these markets that have just have a lower list price. So you see India and China and others that are sequentially and year over year uh growing.

That shows up from an ASP standpoint, as well as introducing DSP and some of that uh touch-up cases that we have. We do see that it's just a
low list price product that ends up uh showing up in ASP. But it was able to help us, you know, in the end, drive volume, as we said, and and ultimately to deliver the margin uh that we needed.

Um and and that's how we we looked at that. I would say when we
think about the the exit rate and you know we're we're factoring in, you know, in our guidance what we saw in Q three, we factor in what we see in in October, and that's what we use to inform our guide. So no change in terms of how we do it or what we look at.

Um it's just a reflection of a a continued challenging market and um things that we're doing to try to help offset

Passages & reports (5)
  • Yeah yeah thanks John. I'll start with ASP. Yes. ASPs were about what we expected. We had …
  • markets that have just have a lower list price. So you see India and China and others that…
  • low list price product that ends up uh showing up in ASP. But it was able to help us, you …
  • think about the the exit rate and you know we're we're factoring in, you know, in our guid…
  • look at. Um it's just a reflection of a a continued challenging market and um things that …

Speaker unclear

?it.

Passages & reports (1)
  • it.

Speaker 5

Thanks, guys.

Passages & reports (1)
  • Thanks, guys.

Speaker 2

Thanks, Sean.

Passages & reports (1)
  • Thanks, Sean.

Speaker 0

Thank ?you. Our next question comes from Brandon Vasquez ?with William Blair. You may proceed.

Passages & reports (5)
  • Thank
  • you. Our
  • next question comes from Brandon Vasquez
  • with
  • William Blair. You may proceed.

Speaker unclear

?Hi,

Passages & reports (1)
  • Hi,

Speaker 2

Brent.

Passages & reports (1)
  • Brent.

Speaker 0

Hi everyone. Thanks

Passages & reports (1)
  • Hi everyone. Thanks

Speaker unclear

?for hey, thanks for taking the

Passages & reports (1)
  • for hey, thanks for taking the

Speaker 6

Unverified voice label

questions. And Joe, congrats on a on a great career at a line and uh good luck on the next steps. ?I wanted to focus first, let's just kind of double click on um ?on the macro a little bit. I think the prior two uh were asking something similar to this, ?but can you talk a little bit more granular about what have things incrementally from Q2 to Q3 on the macro side?

Are there any pockets of things getting worse or better?

Passages & reports (7)
  • questions. And Joe, congrats on a on a great career at a line and uh good luck on the next…
  • I
  • wanted to focus first, let's just kind of double click on um
  • on
  • the macro a little bit. I think the prior two uh were asking something similar to this,
  • but
  • can you talk a little bit more granular about what have things incrementally from Q2 to Q3…

Speaker 0

You know, Joe, I

Passages & reports (1)
  • You know, Joe, I

Speaker unclear

?think you had said North America declined in the quarter in your prepared

Passages & reports (1)
  • think you had said North America declined in the quarter in your prepared

Speaker 6

remarks.

Passages & reports (1)
  • remarks.

Speaker unclear

?Did I hear that correctly? And is

Passages & reports (1)
  • Did I hear that correctly? And is

Speaker 6

that again, is that better or worse? We ?don't always get figures like that. So just curious if you can kind of ?uh level set us on relative to last quarter, how some of the key geographies are doing.

Passages & reports (5)
  • that again, is that better or worse? We
  • don't always get
  • figures like that. So just curious if you can kind of
  • uh
  • level set us on relative to last quarter, how some of the key geographies are doing.

Speaker unclear

?Yeah,

Passages & reports (1)
  • Yeah,

Speaker 2

Brandon, good question. On uh just start with the U.S. where you you started with too or North America. I mean you felt good about Latin America and our performance there was great. Uh I was happy to see that we had positive orthodontic growth for the first time in I think it's the six quarters that we've had in the U.S., which is really positive.

On the GP side, obviously we saw continued erosion. That's a larger bucket of doctors we have to call on. There's challenges across keeping up with those doctors and pushing those doctors, the consumers that we talked about, being a little less reticent, especially
in that can in that um GP channel to convert. So I I I feel, as I you know, mentioned in the script too, I feel good about our ability to to to really push on the GP side.

You see our DSO business there continues to grow. It's that retail segment that's challenging, and
particularly GPs that are doing less than 10 cases a ?year. But I feel we've arranged our workforce properly to be able to go after that. We have good early warning signals signals right now where uh ?we might be losing GPs at different places that we can you know move our Salesforce in in that way.

So um I see a challenged market, a challenged consumer, but I feel good about our product base and I feel about our uh good about our ability to address it.

Passages & reports (8)
  • Brandon, good question. On uh just start with the U.S. where you you started with too or N…
  • quarters that we've had in the U.S., which is really positive. On the GP side, obviously w…
  • in that can in that um GP channel to convert. So I I I feel, as I you know, mentioned in t…
  • particularly GPs that are doing less than 10 cases a
  • year.
  • But I feel we've arranged our workforce properly to be able to go after that. We have good…
  • we
  • might be losing GPs at different places that we can you know move our Salesforce in in tha…

Speaker 3

The products that are really starting to you know take hold. We talked a lot about the no AA or reduced amount of AAA type products, they're growing and across the globe, growing, you know, at a at a triple digit rate, which is great. That's really helping win with doctors, especially in that gray area with that upfront cost. And then we we also talked a lot about and we're seeing more and more, especially in this challenge environment, where those potential patients are are turning to financing to be able to help them afford uh that treatment.

And you see our our partnerships uh with many finance companies,
not just in North America, but it's it's really now become more across the globe. And that's helping win those gray areas as well with those patients. ?It's a good job.

Passages & reports (5)
  • The products that are really starting to you know take hold. We talked a lot about the no …
  • area with that upfront cost. And then we we also talked a lot about and we're seeing more …
  • not just in North America, but it's it's really now become more across the globe. And that…
  • It's
  • a good job.

Speaker 6

Got it. And then ?uh intra quarter, we had gotten a lot of questions around China V VP. ?I know you there's some nuances to your exposure to China and then the private versus the public. Um I don't hopefully I didn't miss something in the prepared remarks, but maybe

Passages & reports (5)
  • Got it. And then
  • uh
  • intra quarter, we had gotten a lot of questions around China V VP.
  • I
  • know you there's some nuances to your exposure to China and then the private versus the pu…

Speaker 5

good

Passages & reports (1)
  • good

Speaker 6

opportunity to kind of level set investors what the potential exposure is uh to China VBP and the orthodontic side, and ?then also what um what kind of is the latest and expectations of timing. Thanks, guys.

Passages & reports (3)
  • opportunity to kind of level set investors what the potential exposure is uh to China VBP …
  • then
  • also what um what kind of is the latest and expectations of timing. Thanks, guys.

Speaker unclear

?Yeah,

Passages & reports (1)
  • Yeah,

Speaker 3

Brandon, this is John. Um so VBP we'll we'll participate in. It's going through its process. I would expect that you know, as as um things open up into the into the fourth quarter in terms of products that will will be entered into it, we'll participate in, as you know, and it's been one well documented. It usually starts on the public side. We don't have a lot of exposure on the on the public side.

Only about fifteen percent of our business in China is public. Most of it's private. Um but we'll participate in in that. We think that it it it helps grow
?uh in in this market where like like we said from a company standpoint, most of our product is on on the private side. Um but the vast majority of cases done in in China are done with wires and brackets.

So if V VP allows more exposure, more more people to
?be able to use clear liners that will help participate and help drive. We feel that with our operations there, our our treatment planning, the Salesforce, everything that we have on a go to market standpoint really will help us um as we navigate through that process.

Passages & reports (6)
  • Brandon, this is John. Um so VBP we'll we'll participate in. It's going through its proces…
  • well documented. It usually starts on the public side. We don't have a lot of exposure on …
  • uh
  • in in this market where like like we said from a company standpoint, most of our product i…
  • be
  • able to use clear liners that will help participate and help drive. We feel that with our …

Speaker 1

Thanks, Brandon. Next question, please.

Passages & reports (1)
  • Thanks, Brandon. Next question, please.

Speaker 0

Thank

Passages & reports (1)
  • Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker unclear

?Our

Passages & reports (1)
  • Our

Speaker 0

next question comes from Vic Chopra with BMO Capital Markets, you may proceed.

Passages & reports (1)
  • next question comes from Vic Chopra with BMO Capital Markets, you may proceed.

Speaker unclear

?Oh

Passages & reports (1)
  • Oh

Speaker 4

hey,

Passages & reports (1)
  • hey,

Speaker unclear

?good afternoon and uh thanks for taking the call, Joe. Best of luck to you and thanks for all your help

Passages & reports (1)
  • good afternoon and uh thanks for taking the call, Joe. Best of luck to you and thanks for …

Speaker 4

um over the past ?few hours. Um the

Passages & reports (3)
  • um over the past
  • few
  • hours. Um the

Speaker unclear

?question for me

Passages & reports (1)
  • question for me

Speaker 3

is on uh

Passages & reports (1)
  • is on uh

Speaker unclear

?twenty twenty-seven framework that you laid

Passages & reports (1)
  • twenty twenty-seven framework that you laid

Speaker 3

out. You've targeted

Passages & reports (1)
  • out. You've targeted

Speaker 4

another hundred basis points of

Passages & reports (1)
  • another hundred basis points of

Speaker unclear

?margin improvement uh without a consumer recovery. Can you talk about the biggest drivers

Passages & reports (1)
  • margin improvement uh without a consumer recovery. Can you talk about the biggest drivers

Speaker 3

of that? ?Um is this a floor or a base case ?and does the Elliott operating review uh is is there potential for that to add to that? Thank

Passages & reports (5)
  • of that?
  • Um
  • is this a floor or a base case
  • and does the
  • Elliott operating review uh is is there potential for that to add to that? Thank

Speaker unclear

?you. John? Yeah

Passages & reports (1)
  • you. John? Yeah

Speaker 3

I could I could start with that big um when ?uh you know we have a lot of productivity and and efficiency programs in place. Obviously we we we know how to manufacture and manufacture at scale and better drive productivity. So many of the actions that we've been doing for the last several years are coming to fruition and we're driving that is that improved productivity.

We're seeing that this year we see the gross margin improvements that we've had in the business. Some of it's product related where you have that less dependence on these complicated uh products that have multiple refinements and we go to fewer refinement type products, you know, that drives a lot of productivity in our
business. So some of it's at the product level, some of it's at the initiatives that we have to be able to help drive improvements and in productivity.

Of course we're we're going through this you know strategic review and understanding where we can save money, where we can invest to be able to to
drive growth and and do it in a profitable way. So we feel good about the the efforts that we have up until this point. We'll continue to make refinements to it and and then at the end of uh Q4 here we'll be prepared to talk about what that means for uh twenty twenty-seven.

Passages & reports (6)
  • I could I could start with that big um when
  • uh you
  • know we have a lot of productivity and and efficiency programs in place. Obviously we we w…
  • We're seeing that this year we see the gross margin improvements that we've had in the bus…
  • business. So some of it's at the product level, some of it's at the initiatives that we ha…
  • drive growth and and do it in a profitable way. So we feel good about the the efforts that…

But we hold to the fact ?that the the op margin improvement next year that we've committed to, that at least a hundred basis point improvement um is is progressing well and we'll update more about what that means for the rest of the PNL um next quarter.

Passages & reports (3)
  • But we hold to the fact
  • that
  • the the op margin improvement next year that we've committed to, that at least a hundred b…

Speaker 0

Thank

Passages & reports (1)
  • Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker unclear

?Our

Passages & reports (1)
  • Our

Speaker 0

next question comes from Jeff Johnson with Beard. You may proceed.

Passages & reports (1)
  • next question comes from Jeff Johnson with Beard. You may proceed.

Speaker unclear

?Yeah, thanks.

Passages & reports (1)
  • Yeah, thanks.

Speaker 7

Unverified voice label

Good afternoon, guys. And Joe, uh again, I'll just add the congrats on a great career and uh good luck in retirement. Uh let me ask one follow-up question on VBP if I could, and then I want to ask a case volume question as well. ?But uh John, on VVP, obviously a lot of moving parts, as you said, maybe getting bigger into the public side uh if if you bid on uh on on that side of the business uh here in this round.

Uh on on the on the private side, we are hearing the Chinese government kind
?of pushing for private uh docs to also participate uh from a pricing perspective in in VBP. You know, I guess net, we don't know how that's going to play out, but but should VBP be a good guy, a bad guy for you guys next year? Uh there's all the moving parts on what happens in your private market pricing pricing versus if you get uh public market incremental volume.

So help us out maybe on just net how we should think about

Passages & reports (6)
  • Good afternoon, guys. And Joe, uh again, I'll just add the congrats on a great career and …
  • But
  • uh John, on VVP, obviously a lot of moving parts, as you said, maybe getting bigger into t…
  • of
  • pushing for private uh docs to also participate uh from a pricing perspective in in VBP. Y…
  • in your private market pricing pricing versus if you get uh public market incremental volu…

Speaker unclear

?this?

Passages & reports (1)
  • this?

Speaker 2

Well, as uh you're

Passages & reports (1)
  • Well, as uh you're

Speaker unclear

?right, there are a lot of moving pieces to it, Jeff. And I think when you look at it

Passages & reports (1)
  • right, there are a lot of moving pieces to it, Jeff. And I think when you look at it

Speaker 3

as, you know,

Passages & reports (1)
  • as, you know,

Speaker unclear

?if it gets it, it will get to private

Passages & reports (1)
  • if it gets it, it will get to private

Speaker 2

as it goes to private, the real question will become is what doctors do with those those price differences. Do they pass them on to the b the

Passages & reports (1)
  • as it goes to private, the real question will become is what doctors do with those those p…

Speaker unclear

?potential patients? We hope they do, because that will drive an

Passages & reports (1)
  • potential patients? We hope they do, because that will drive an

Speaker 2

increased amount

Passages & reports (1)
  • increased amount

Speaker 3

of utilization and adoption of clear liners. ?So we hope

Passages & reports (3)
  • of utilization and adoption of clear liners.
  • So
  • we hope

Speaker 2

that that's

Passages & reports (1)
  • that that's

Speaker 3

uh where it ends up going.

Passages & reports (1)
  • uh where it ends up going.

Speaker 2

But we

Passages & reports (1)
  • But we

Speaker 3

see um we see increased um volume that'll come through. That's typically what happens with B VP. We think we're properly positioned

Passages & reports (1)
  • see um we see increased um volume that'll come through. That's typically what happens with…

Speaker 2

in China ?to be able to kind of in China for China to be able to manage the cost. And and I think when you look at it overall from a ?you know a net net revenue standpoint, it's ?to us it's

Passages & reports (7)
  • in China
  • to be able
  • to kind of in China for China to be able to manage the cost. And and I think when you look…
  • you
  • know a net net revenue standpoint, it's
  • to us
  • it's

Speaker 3

neutral uh to to positive. Just from the standpoint you're going to drive a lot of volume, I think uh as it as it works its way through the system. And um you will have some price, but I think the volume helps offset it. And as long as you know that part product portfolio that we have uh is is in place as well as some of the in China uh operations we have, we think we're properly positioned.

Passages & reports (2)
  • neutral uh to to positive. Just from the standpoint you're going to drive a lot of volume,…
  • that we have uh is is in place as well as some of the in China uh operations we have, we t…

Speaker 2

Good job.

Passages & reports (1)
  • Good job.

Speaker unclear

?All

Passages & reports (1)
  • All

Speaker 7

right. Fair enough. And then just on the case volume side, ?you know, you're guiding low single digits for four Q. I think when I think about how you guided 26 previously on last quarter's call and guided 3Q on the 2Q call, feels like that 4Q case volume guidance globally is maybe down a point or two relative to what you were thinking. You know, just taking your pulse on that is is that about right?

Maybe a point or two lighter than you would have been expecting, number one. And you'll hit very similar comps. You hit a seven plus comp here in the fourth quarter. The next few comps into twenty-seven are going to be similar. Is that kind
of low single digit for four Q against a seven plus comp about the way we should think about coming up against those other seven percent comps th through the first few quarters of of next year as well?

Thanks.

Passages & reports (5)
  • right. Fair enough. And then just on the case volume side,
  • you
  • know, you're guiding low single digits for four Q. I think when I think about how you guid…
  • taking your pulse on that is is that about right? Maybe a point or two lighter than you wo…
  • of low single digit for four Q against a seven plus comp about the way we should think abo…

Speaker 2

You're you're right from a stack standpoint. The stack is is very similar similar to the two year stack that we've seen, you know, with

Passages & reports (1)
  • You're you're right from a stack standpoint. The stack is is very similar similar to the t…

Speaker 3

Q three and then and then kind of the implied guidance for for Q four. So uh you get you get to that uh Jeff. I think what you see is um you know continued um consumer uh c that's

Passages & reports (1)
  • Q three and then and then kind of the implied guidance for for Q four. So uh you get you g…

Speaker 2

challenged

Passages & reports (1)
  • challenged

Speaker 3

across many markets. You've got to do a lot of things to try to motivate them to go into treatment when they have that ?is that challenge. Uh financing some of the product portfolio and other things that we're trying to do to help with the go to market effort. So um you know slight uh tweaks that we've made based on what we're seeing on a global basis, but um but in that overall revenue uh that we're talking about for the year of that 5 to 6% and similar amount from a volume standpoint for Clearliner.

So overall, that hasn't changed too much from the total year standpoint, but just adjusting slightly for Q4.

Passages & reports (4)
  • across many markets. You've got to do a lot of things to try to motivate them to go into t…
  • is that challenge.
  • Uh financing some of the product portfolio and other things that we're trying to do to hel…
  • the year of that 5 to 6% and similar amount from a volume standpoint for Clearliner. So ov…

Speaker 0

Thank

Passages & reports (1)
  • Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker unclear

?Our

Passages & reports (1)
  • Our

Speaker 0

next question comes from Elizabeth Anderson with Evercore ISI. You may proceed.

Passages & reports (1)
  • next question comes from Elizabeth Anderson with Evercore ISI. You may proceed.

Speaker 1

Hi guys. Good

Passages & reports (1)
  • Hi guys. Good

Speaker unclear

?afternoon. Thanks for the question and

Passages & reports (1)
  • afternoon. Thanks for the question and

Speaker 1

congratulations, Joe, ?on your retirement. I

Passages & reports (3)
  • congratulations, Joe,
  • on your
  • retirement. I

Speaker unclear

?wanted to dig in a little

Passages & reports (1)
  • wanted to dig in a little

Speaker 1

bit on the scanner side. I mean, if we think about the the implied scanner guide, it's a little bit lower, I think, than expectations, but also, you know, to Jeff's just point now, the comps get a lot tougher. So I guess how do we think about it kind of labbing last year's upgrade sales? You talked about the lower price scanner mix after leasing, some of the capital leasing that you're sort of offered.

Like, I guess could you help us double click on some of those different components so we can sort of understand the lay of the landscape for that demand environment and sort of how
to think about that um going forward. Thank you.

Passages & reports (3)
  • bit on the scanner side. I mean, if we think about the the implied scanner guide, it's a l…
  • sales? You talked about the lower price scanner mix after leasing, some of the capital lea…
  • to think about that um going forward. Thank you.

Speaker 2

Yeah, that's a good question, Elizabeth. This is John. Um ?so first of all, our scanner um equipment sales that we have, the unit volume is has been very strong. We see the installed base up double digit. So we're getting good adoption of our scanners, and we're very pleased with

Passages & reports (3)
  • Yeah, that's a good question, Elizabeth. This is John. Um
  • so
  • first of all, our scanner um equipment sales that we have, the unit volume is has been ver…

Speaker 3

that. That's ?a great scanner, great

Passages & reports (3)
  • that. That's
  • a
  • great scanner, great

Speaker 2

portfolio we have, being able to get

Passages & reports (1)
  • portfolio we have, being able to get

Speaker 3

to those doctors. Some still

Passages & reports (1)
  • to those doctors. Some still

Speaker 2

want to have the the latest and greatest, Lumina, all the bells and whistles,

Passages & reports (1)
  • want to have the the latest and greatest, Lumina, all the bells and whistles,

Speaker 3

great. And that comes through as equipment sell through. Uh some some doctors are like, I don't need the full system, I'll I'll do more of a flex model where they just hook into a laptop and it's it's fits their needs. Some doctors are looking at maybe the certified pre owned. Any which way they want those units, we're happy to sell. It just whatever fits their needs.

The added component that we've seen is a lot more leasing, a lot more rental. And those doctors are like, I we just we want the scanner, I just don't want to pay for it up front. So we're seeing a
uh those placements happening. You're starting to build up more of that rental uh income because it's from previous quarter or rental revenue that's from previous quarters that's now building up into whatever current quarter you're in, as well as leasing and so on.

So that's an evolution that continues to happen within the business.

Passages & reports (3)
  • great. And that comes through as equipment sell through. Uh some some doctors are like, I …
  • they want those units, we're happy to sell. It just whatever fits their needs. The added c…
  • uh those placements happening. You're starting to build up more of that rental uh income b…

What we saw as we went from second quarter to third quarter, we saw relatively stable pricing on an overall uh equipment standpoint. So that was a good sign for us ?that it's kind of more bottomed out there from a price standpoint. And we feel good that we can build off of that for Q4.

Passages & reports (3)
  • What we saw as we went from second quarter to third quarter, we saw relatively stable pric…
  • that
  • it's kind of more bottomed out there from a price standpoint. And we feel good that we can…

Speaker 2

And more importantly, as we b look into twenty twenty seven, we build

Passages & reports (1)
  • And more importantly, as we b look into twenty twenty seven, we build

Speaker unclear

?off of that

Passages & reports (1)
  • off of that

Speaker 3

to twenty seven such that we expect systems and services to grow next year because the pricing has stabilized because of the the trades that the trade offs that are happening between equipment sale and and leasing. So that when we look at twenty twenty seven it's it's much more stable and as we've said in the past, as we've talked about, you know, you get about the same growth between um the equipment side of our business as well as a clear liner side.

And that's what what our expectation would be for next year.

Passages & reports (2)
  • to twenty seven such that we expect systems and services to grow next year because the pri…
  • in the past, as we've talked about, you know, you get about the same growth between um the…

Speaker 1

And then if we think about that scanner growth and you talk about the switch to leasing, we've obviously historically seen a really nice attach rate of of case growth to that those scanner sales. Are you seeing anything different in the attach rate in terms of new cases from one of those placements or leases or or secondhand sales as what we've seen historically versus sort of when you just had the the the prior model of just new sort of sales.

Passages & reports (2)
  • And then if we think about that scanner growth and you talk about the switch to leasing, w…
  • leases or or secondhand sales as what we've seen historically versus sort of when you just…

Speaker 2

Yeah, what you see is um you see doctors who might not have wanted to go and you know use our scanner. What we see, we we talked to about a record number of submitters that we have in the

Passages & reports (1)
  • Yeah, what you see is um you see doctors who might not have wanted to go and you know use …

Speaker unclear

?quarter. Some of that is is helping by

Passages & reports (1)
  • quarter. Some of that is is helping by

Speaker 2

being able

Passages & reports (1)
  • being able

Speaker unclear

?to get a

Passages & reports (1)
  • to get a

Speaker 3

scanner that they might not have gone to before. The acquisition costs is less because they're leasing it to just this monthly fee that they pay and then it starts the front end of the digital ecosystem they're starting to use invisalign and and digitize so that it it helps them grow their business um in a digital orthodontic way so we like this the the the combination of being able to help them digitize their practice and really be um as efficient and beneficial for their patients as possible.

Passages & reports (2)
  • scanner that they might not have gone to before. The acquisition costs is less because the…
  • in a digital orthodontic way so we like this the the the combination of being able to help…

Speaker 1

Thanks Elizabeth next question please

Passages & reports (1)
  • Thanks Elizabeth next question please

Speaker 0

thank ?you our next question comes from Jason Bednar with Piper Handler. You may proceed.

Passages & reports (3)
  • thank
  • you our
  • next question comes from Jason Bednar with Piper Handler. You may proceed.

Speaker unclear

?Hi

Passages & reports (1)
  • Hi

Speaker 6

there. Good afternoon. Uh Joe,

Passages & reports (1)
  • there. Good afternoon. Uh Joe,

Speaker 2

I'll

Passages & reports (1)
  • I'll

Speaker 6

just echo the the congrats there and uh pleasure pleasure working with you over the past several years.

Passages & reports (1)
  • just echo the the congrats there and uh pleasure pleasure working with you over the past s…

Speaker unclear

?Um

Passages & reports (1)
  • Um

Speaker 6

guys, I I I do appreciate the color here on on 2027, the framework there. ?Uh maybe I want to you know layer on to some of the questions earlier. I know this business can be tough to predict at times, but you are throwing out some initial guardrails or floors, whatever you want to call them. Um, you know, are what are the macro assumptions you're embedding in that aligner outlook?

Is it more or less status quo for the US and international? Uh and then can you get a little bit more detailed? Uh we've been poking around at some of the different moving parts, but
?uh just on on the ASP outlook, what are the puts and takes that are uh contributing to the the 2027 framework?

Passages & reports (6)
  • guys, I I I do appreciate the color here on on 2027, the framework there.
  • Uh
  • maybe I want to you know layer on to some of the questions earlier. I know this business c…
  • outlook? Is it more or less status quo for the US and international? Uh and then can you g…
  • uh
  • just on on the ASP outlook, what are the puts and takes that are uh contributing to the th…

Speaker unclear

?Yeah,

Passages & reports (1)
  • Yeah,

Speaker 2

I mean when we look at 2027 framework, first off, we're not expecting much of a change in the overall consumer. The consumer will will be what it does. Uh it's a challenging uh environment for inflation and other

Passages & reports (1)
  • I mean when we look at 2027 framework, first off, we're not expecting much of a change in …

Speaker 3

inputs that those potential patients have. So we're not expecting really a change from that. What we are pushing and helping drive is how do we go to market with uh various products and combinations to be able to get to our doctors to be able to help ?them uh start cases, uh ultimately do more cases. You couple that with financing to those those ?potential patients, really trying to ?get those reluctant uh patients to to actually get into treatment.

So that's how we're building uh throughout this year in this challenging environment and what we would expect uh for next year. As we think about our growth and what we've seen from a growth this year and our expectation for next year
?is look, you're gonna you're gonna see some of those markets where we've had great growth on the international side we'd expect those to to continue.

India and and China and Latin America and others, they're gonna continue. Those are are great growth opportunities for us. That continues. They come at at a lower list price.
It's just what the market is. You're also going to see some of these products like the DSP, touch-up cases, and so on, that will end up, you know, we end up growing faster too.

Those two combinations, geographic plus product mix, take our ASPs

Passages & reports (10)
  • inputs that those potential patients have. So we're not expecting really a change from tha…
  • them
  • uh start cases, uh ultimately do more cases. You couple that with financing to those those
  • potential
  • patients, really trying to
  • get
  • those reluctant uh patients to to actually get into treatment. So that's how we're buildin…
  • is
  • look, you're gonna you're gonna see some of those markets where we've had great growth on …
  • It's just what the market is. You're also going to see some of these products like the DSP…

Speaker 2

down, and what we've been seeing is ?that one to two ?percent. This year it'll

Passages & reports (5)
  • down, and what we've been seeing is
  • that one
  • to two
  • percent. This year
  • it'll

Speaker unclear

?be up down about one

Passages & reports (1)
  • be up down about one

Speaker 3

percent, but I think from a planning standpoint through that geographic and product mix about one to

Passages & reports (1)
  • percent, but I think from a planning standpoint through that geographic and product mix ab…

Speaker unclear

?two percent.

Passages & reports (1)
  • two percent.

Speaker 6

Okay. ?Uh that's awful and uh maybe I'll follow up just on scanners of services uh you know to follow up on Elizabeth's question previously um ?you know can where does the confidence come from that twenty six here will be the bottom and that the shift to the per like an alternate purchasing model won't gain further momentum as we move into next year.

Um I guess just wonder where the confidence lies that this isn't some secular shift um that
you won't see again again play out again next

Passages & reports (6)
  • Okay.
  • Uh
  • that's awful and uh maybe I'll follow up just on scanners of services uh you know to follo…
  • you
  • know can where does the confidence come from that twenty six here will be the bottom and t…
  • you won't see again again play out again next

Speaker unclear

?year.

Passages & reports (1)
  • year.

Speaker 2

Yeah. You know, think about it, Jason. We've got from a new product standpoint, we've certainly seen some of that price shifting. And we started seeing this in the first quarter really played

Passages & reports (1)
  • Yeah. You know, think about it, Jason. We've got from a new product standpoint, we've cert…

Speaker 3

out in the second quarter. It was stable in the third quar in the third quarter, meaning that pricing was was about equal and this is really across the globe. So what we also see is strong demand. There is demand for this product. That installed base growing like it is the product is well received.

Passages & reports (2)
  • out in the second quarter. It was stable in the third quar in the third quarter, meaning t…
  • received.

Speaker 2

All the products that we have are well received. It's just

Passages & reports (1)
  • All the products that we have are well received. It's just

Speaker unclear

?that

Passages & reports (1)
  • that

Speaker 3

in in some cases that's it's at a lower price, but we think that's stabilized. And then when you look at the leasing and rental, some markets have shifted to that. Um it's it isn't in all the markets, but in some markets it's shifted to that. And what you do

Passages & reports (1)
  • in in some cases that's it's at a lower price, but we think that's stabilized. And then wh…

Speaker unclear

?is you just

Passages & reports (1)
  • is you just

Speaker 2

forego

Passages & reports (1)
  • forego

Speaker 3

as much, ?you know, you don't get as much revenue up front, but you get that revenue later on. The key for us is we want those doctors to be able to have that scanner at their practice, help them digitize, and lead to more use of digital orthodontics. ?And we think that's a good thing and and we're expecting to build on that um as we go into 2027.

Passages & reports (5)
  • as much,
  • you
  • know, you don't get as much revenue up front, but you get that revenue later on. The key f…
  • And
  • we think that's a good thing and and we're expecting to build on that um as we go into 202…

Speaker 1

Thanks. Thanks, Jason. Next question, please.

Passages & reports (1)
  • Thanks. Thanks, Jason. Next question, please.

Speaker 0

Thank ?you. Our next question comes from Stephen Balaket with Mizuho Securities. He may proceed.

Passages & reports (3)
  • Thank
  • you.
  • Our next question comes from Stephen Balaket with Mizuho Securities. He may proceed.

Speaker unclear

?Yeah,

Passages & reports (1)
  • Yeah,

Speaker 4

thanks. ?Good afternoon, everybody. Let me

Passages & reports (3)
  • thanks.
  • Good afternoon,
  • everybody. Let me

Speaker 3

also offer my uh congrats to Joe on eleven plus years of successful leadership at a line. Um yeah, I guess just for me, again, not to ask too many questions on 2027 overall in this call, but the uh ?you know the comment again about expecting it to continue to drive and misaligned volume growth in 2027. ?I know it's kind of intentionally vague because it's a preliminary view and you have to be left wide open to interpretation.

So I guess
?I don't know if there's you know a a a f further you know message within that. Um I'm just trying to confirm maybe yes or no. Is there anything

Passages & reports (7)
  • also offer my uh congrats to Joe on eleven plus years of successful leadership at a line. …
  • you know
  • the comment again about expecting it to continue to drive and misaligned volume growth in …
  • I
  • know it's kind of intentionally vague because it's a preliminary view and you have to be l…
  • I don't
  • know if there's you know a a a f further you know message within that. Um I'm just trying …

Speaker unclear

?you know structurally that you know right now

Passages & reports (1)
  • you know structurally that you know right now

Speaker 6

that would prevent the growth in

Passages & reports (1)
  • that would prevent the growth in

Speaker 3

2027 being similar to ?the mid-signal data you have in 2026. Without stating the obvious, you know, something like five to ten percent growth would be phenomenal, but you know one percent growth, while it's growth would not be viewed great right now relative to expectations and consensus, et cetera. So hopefully that you know the question makes sense. Thanks.

Passages & reports (3)
  • 2027 being similar to
  • the
  • mid-signal data you have in 2026. Without stating the obvious, you know, something like fi…

Speaker 2

Look, I I think Steve, this is John. So when you think of um what we're trying to do, it's it's we're expecting a challenging macro environment. I don't know if it magically gets

Passages & reports (1)
  • Look, I I think Steve, this is John. So when you think of um what we're trying to do, it's…

Speaker 3

better uh into

Passages & reports (1)
  • better uh into

Speaker 2

next year. So given that,

Passages & reports (1)
  • next year. So given that,

Speaker 3

um

Passages & reports (1)
  • um

Speaker 2

the work

Passages & reports (1)
  • the work

Speaker 3

that we're doing

Passages & reports (1)
  • that we're doing

Speaker 2

from the product portfolio and what ?we're doing to go to market,

Passages & reports (3)
  • from the product portfolio and what
  • we're doing
  • to go to market,

Speaker 3

uh, as well as some of that consumer and other financing uh options to be able to help with those those

Passages & reports (1)
  • uh, as well as some of that consumer and other financing uh options to be able to help wit…

Speaker 2

uh

Passages & reports (1)
  • uh

Speaker unclear

?potential

Passages & reports (1)
  • potential

Speaker 3

patients to go into to treatment. It served us well this year when we think about our our clear liner uh revenue and volume uh as we talked about for the full year of that five to six percent. Uh that's that served us well in in twenty twenty-six. Uh we'll give more details about what it means for twenty twenty-seven um in light of all the uh ?you know the efforts that we have going on, but we feel good about um what we're trying to do to try to drive that utilization and adoption uh go to market because the underlying overall market hasn't changed.

Passages & reports (4)
  • patients to go into to treatment. It served us well this year when we think about our our …
  • what it means for twenty twenty-seven um in light of all the uh
  • you
  • know the efforts that we have going on, but we feel good about um what we're trying to do …

Speaker 2

The vast majority of cases are still done with wires and brackets.

Passages & reports (1)
  • The vast majority of cases are still done with wires and brackets.

Speaker 3

And we have that opportunity to grow in this in this uh space. It's just that macro that we have to we have to work against, and that's why we want to make sure ?that uh we can continue to grow.

Passages & reports (3)
  • And we have that opportunity to grow in this in this uh space. It's just that macro that w…
  • that
  • uh we can continue to grow.

Speaker 2

Yeah, I think what I want to emphasize too, and just support John's comments, is because there's a lot of questions on 2027. We're not predicting 2027 is going to fall off in some way. Just like John said, we expect very you know we can't predict what the economy is going to be look like. We feel good about our ability to execute in a difficult situation from a consumer standpoint, and we'll continue to execute that

Passages & reports (2)
  • Yeah, I think what I want to emphasize too, and just support John's comments, is because t…
  • like. We feel good about our ability to execute in a difficult situation from a consumer s…

Speaker unclear

?way.

Passages & reports (1)
  • way.

Speaker 2

Okay,

Passages & reports (1)
  • Okay,

Speaker unclear

?that's

Passages & reports (1)
  • that's

Speaker 1

helpful. ?Thanks. Next question please

Passages & reports (3)
  • helpful.
  • Thanks.
  • Next question please

Speaker 0

thank ?you. Our next question comes from Aaron Wright with Morgan Stanley, you may proceed.

Passages & reports (3)
  • thank
  • you.
  • Our next question comes from Aaron Wright with Morgan Stanley, you may proceed.

Speaker unclear

?Great, thanks. And and congrats to again. It was great working with you.

Passages & reports (1)
  • Great, thanks. And and congrats to again. It was great working with you.

Speaker 3

You ?mentioned financing a few times now, and ?I guess can you

Passages & reports (5)
  • You
  • mentioned
  • financing a few times now, and
  • I
  • guess can you

Speaker unclear

?speak to some of the newer financing initiatives in terms of where that stands in terms of the

Passages & reports (1)
  • speak to some of the newer financing initiatives in terms of where that stands in terms of…

Speaker 3

rollout ?of those and and just anything ?that you can give us in terms of how

Passages & reports (5)
  • rollout
  • of
  • those and and just anything
  • that you
  • can give us in terms of how

Speaker unclear

?that's translating into conversion? And then and then just a second question just on macro um and the pressures that

Passages & reports (1)
  • that's translating into conversion? And then and then just a second question just on macro…

Speaker 6

you're ?seeing. Like

Passages & reports (3)
  • you're
  • seeing.
  • Like

Speaker unclear

?what are you seeing in terms of, you know, also like share

Passages & reports (1)
  • what are you seeing in terms of, you know, also like share

Speaker 6

shifts back to brackets ?and wires or something ?like that, or is it just purely underlying kind of demand trend and who's walking in the front door?

Passages & reports (5)
  • shifts back to brackets
  • and
  • wires or something
  • like that, or is
  • it just purely underlying kind of demand trend and who's walking in the front door?

Speaker unclear

?Okay, thanks.

Passages & reports (1)
  • Okay, thanks.

Speaker 2

Maybe I could start

Passages & reports (1)
  • Maybe I could start

Speaker 3

with the some of the financing.

Passages & reports (1)
  • with the some of the financing.

Speaker 2

Um we're seeing uh many countries and many regions adopting financing using external financing that really haven't done it before. And we're helping lead the way and and do it in a way where we're working with some of these these financing companies,

Passages & reports (1)
  • Um we're seeing uh many countries and many regions adopting financing using external finan…

Speaker 3

um, being

Passages & reports (1)
  • um, being

Speaker 2

able to get

Passages & reports (1)
  • able to get

Speaker 3

them into those offices through our sales

Passages & reports (1)
  • them into those offices through our sales

Speaker 2

team, be able to talk about

Passages & reports (1)
  • team, be able to talk about

Speaker 3

the financing

Passages & reports (1)
  • the financing

Speaker 2

op options. Uh more and more in this environment, people are looking for ways to be able to afford things. And that gets ultimately down to a month by month

Passages & reports (1)
  • op options. Uh more and more in this environment, people are looking for ways to be able t…

Speaker 3

basis. So I would say, Aaron, you're seeing this uh much broader across the US and it's helping us win those gray areas with those potential patients. And what I'm really encouraged about is we're solving some of these in in Europe that we never really thought we could get through. These finance companies are now uh much more willing to partner with us and and be

Passages & reports (2)
  • basis. So I would say, Aaron, you're seeing this uh much broader across the US and it's he…
  • now uh much more willing to partner with us and and be

Speaker 2

partners with us to be able to help provide financing uh solutions to consumers. So it's early that we're seeing this, but it's good progress and we feel good about um this as being a differentiator to help, especially in this economy, uh, to be able to help grow the business. And in your second part of your question, Aaron, about um wires and brackets and how we're doing, remember majority of the cases we do are adults still. ?

Uh
from a teen standpoint, we you know you hear more and more about about wires and brackets and different things. ?But as I mentioned in my script, we really feel good about the early intervention that we have. When you look at Invisalign First, you look at IPE, mandibular advancements, those products are growing at double digits for us right now. And it gives us really good access into that teen and tween marketplace overall.

So we'll
keep pushing those products and we'll keep driving adults too. And that's our shift happens piece, is aimed right at that to help the orthodontists grow their their adult side and then also with it the GP side also. So ?I feel good about our go-to-market, market both in product and also from a marketing standpoint.

Passages & reports (9)
  • partners with us to be able to help provide financing uh solutions to consumers. So it's e…
  • part of your question, Aaron, about um wires and brackets and how we're doing, remember ma…
  • Uh
  • from a teen standpoint, we you know you hear more and more about about wires and brackets …
  • But as
  • I mentioned in my script, we really feel good about the early intervention that we have. W…
  • keep pushing those products and we'll keep driving adults too. And that's our shift happen…
  • I
  • feel good about our go-to-market, market both in product and also from a marketing standpo…

Speaker 1

Thanks, Aaron. Next question, please.

Passages & reports (1)
  • Thanks, Aaron. Next question, please.

Speaker 0

Thank ?you. Our next question comes from Kevin Caliendo with UBS, He May Proceed.

Passages & reports (3)
  • Thank
  • you. Our
  • next question comes from Kevin Caliendo with UBS, He May Proceed.

Speaker 6

Hi, thanks ?for taking my question. Uh Joe, good luck with everything going forward in case we are cross our paths don't cross again.

Passages & reports (3)
  • Hi, thanks
  • for taking my question.
  • Uh Joe, good luck with everything going forward in case we are cross our paths don't cross…

Speaker unclear

?I

Passages & reports (1)
  • I

Speaker 6

wanted to talk about the mouth guard a little bit ?because it's certainly

Passages & reports (3)
  • wanted to talk about the mouth guard a little bit
  • because it's
  • certainly

Speaker unclear

?interesting. Is this

Passages & reports (1)
  • interesting. Is this

Speaker 3

is this a product

Passages & reports (1)
  • is this a product

Speaker unclear

?that's do you anticipate

Passages & reports (1)
  • that's do you anticipate

Speaker 6

distributing through ?like a retail channel?

Passages & reports (3)
  • distributing through
  • like a retail
  • channel?

Speaker unclear

?Meaning, are you gonna

Passages & reports (1)
  • Meaning, are you gonna

Speaker 7

go to ?Dick Sporting Goods and see an align mouth guard? Or is it ?a mouth guard ?that's going to be specific

Passages & reports (7)
  • go to
  • Dick
  • Sporting Goods and see an align mouth guard? Or is it
  • a mouth
  • guard
  • that's going to be
  • specific

Speaker unclear

?for you know people that might be going to the orthodontist already or a

Passages & reports (1)
  • for you know people that might be going to the orthodontist already or a

Speaker 6

GP?

Passages & reports (1)
  • GP?

Speaker unclear

?Like where's the end user gonna gonna learn about these mouth guards? And I guess the pricing strategy here is this like a premium product versus a a

Passages & reports (1)
  • Like where's the end user gonna gonna learn about these mouth guards? And I guess the pric…

Speaker 6

generic product? Um, because it doesn't sound like generic if you have s some kind of uh resin that's proprietary. And I guess

Passages & reports (1)
  • generic product? Um, because it doesn't sound like generic if you have s some kind of uh r…

Speaker unclear

?I guess my

Passages & reports (1)
  • I guess my

Speaker 5

concern is if

Passages & reports (1)
  • concern is if

Speaker unclear

?you sell it somewhere that's not in a retail setting,

Passages & reports (1)
  • you sell it somewhere that's not in a retail setting,

Speaker 6

does it potentially impact the retainer business? Because I'm guessing the pricing of a retainer might ?be a lot more than ?a mouth guard. ?But I'd just love

Passages & reports (7)
  • does it potentially impact the retainer business? Because I'm guessing the pricing of a re…
  • be a lot
  • more than
  • a
  • mouth guard.
  • But
  • I'd just love

Speaker unclear

?to hear a little bit about the strategy and more about the

Passages & reports (1)
  • to hear a little bit about the strategy and more about the

Speaker 7

mouth

Passages & reports (1)
  • mouth

Speaker unclear

?guard. Yeah,

Passages & reports (1)
  • guard. Yeah,

Speaker 2

hey this it's a good question. First of all, um we won't be selling it directly to consumers. That's that's not the game. We the channels that we want to work it through with Orthodonists really asking for this product line because of their strong team marketplace. And I know parents are very concerned in that way. And we think our GP channel will do it too.

So we will keep with our channel strategy and not go outside that from an OEM standpoint. It is a premium product overall. When you look at it from a retainer standpoint, it won't hurt the retainer business at all because it's just
completely different functionality overall. It is very unique, as I mentioned. It's really the only truly 3D printed mouth guard that we know with this kind of unique resin, and we have a lot of obviously design flexibility in order to make it as comfortable and as functional as we possibly can for athletes.

And
we like the idea that they can kind of design the mouth guard that they want. ?Uh and we'll stay, you know, within those protective procedures for that particular sport. So I see this as just right in line with our with our channel strategy. It's right in line with our technical strategy with 3D printing. Um it's a big opportunity for us overall.

Passages & reports (6)
  • hey this it's a good question. First of all, um we won't be selling it directly to consume…
  • that way. And we think our GP channel will do it too. So we will keep with our channel str…
  • completely different functionality overall. It is very unique, as I mentioned. It's really…
  • we like the idea that they can kind of design the mouth guard that they want.
  • Uh
  • and we'll stay, you know, within those protective procedures for that particular sport. So…

Speaker 6

If ?I can ask a quick follow-up, I've got some soccer and uh hockey and football parents asking me to ask is this something that you can strap onto a helmet?

Passages & reports (3)
  • If
  • I can
  • ask a quick follow-up, I've got some soccer and uh hockey and football parents asking me t…

Speaker 2

Because they always get

Passages & reports (1)
  • Because they always get

Speaker unclear

?lost and

Passages & reports (1)
  • lost and

Speaker 6

chewed upon.

Passages & reports (1)
  • chewed upon.

Speaker unclear

?You

Passages & reports (1)
  • You

Speaker 2

know, Kevin, I have two answers to that. One is we can 3D print that we can make it any way you want to. So if you want to have a strap on it that snaps, we could do that. But secondly, we plan to make these things so comfortable the kids aren't going to want to take them out of their ?mouth. A lot of time, what our research basically is they take it out because they can't speak. ?

Uh
oftenly they can't swallow properly and they have to pull that out. They lose it on their helmets. So ?all right, that's that's again why we like this technology. We can design this in a different way because it is a higher performance resin and a much more uh capable design ?uh criterion than what you could go with boil and bite and and form and uh foreman fill kind ?of mouth guards now.

Passages & reports (12)
  • know, Kevin, I have two answers to that. One is we can 3D print that we can make it any wa…
  • want to take them out of their
  • mouth.
  • A lot of time, what our research basically is they take it out because they can't speak.
  • Uh
  • oftenly they can't swallow properly and they have to pull that out. They lose it on their …
  • all
  • right, that's that's again why we like this technology. We can design this in a different …
  • uh
  • criterion than what you could go with boil and bite and and form and uh foreman fill kind
  • of
  • mouth guards now.

Speaker unclear

?Interesting. Well, so thank you so much.

Passages & reports (1)
  • Interesting. Well, so thank you so much.

Speaker 2

Yeah, you're welcome.

Passages & reports (1)
  • Yeah, you're welcome.

Speaker unclear

?Thanks for

Passages & reports (1)
  • Thanks for

Speaker 0

having me. Thank ?you. Thank you. And we have reached the end of our question and answer session. I will now turn the call back over to Shirley Stacy for any closing remarks.

Passages & reports (3)
  • having me. Thank
  • you.
  • Thank you. And we have reached the end of our question and answer session. I will now turn…

Speaker 1

Thank you everyone for joining us today. We look forward to meeting and speaking with you at upcoming investor conferences and industry meetings. If you have any follow-up questions or need more information, please contact Align Investor Relations. Thanks and have a great

Passages & reports (1)
  • Thank you everyone for joining us today. We look forward to meeting and speaking with you …

Speaker unclear

?day.

Passages & reports (1)
  • day.

Speaker 0

Thank you. This concludes today's conference. And you may disconnect your lines at this time. Thank you for your participation.

Passages & reports (1)
  • Thank you. This concludes today's conference. And you may disconnect your lines at this ti…
Source, accuracy & exportsMay contain errorsAccuracy unmeasured. Speakers are anonymous voice labels, local to this call. No names are verified. Section starts and timestamps are inferred. Speakers are anonymous voice labels, local to this call. No names are verified. Section starts and timestamps are inferred.

Short unclear spans may appear inline between matching voice IDs. The ? marker retains unknown attribution; no voice identity is inferred for those words.

AI-generated transcript; names, numbers and wording may be inaccurate.

Speaker IDs are anonymous and local to this call. Section boundaries and timestamps are inferred.

4 words have zero-duration alignments. Use surrounding audio; no timing has been repaired.

The diarizer reached its eight-speaker limit; distinct voices may share an ID.

Zero-duration alignments: 4. Unassigned words: 548. No alignment has been repaired. Timestamps locate passages in the source recording; decimal positions do not establish word-level precision.

Official issuer source ↗ · Report an issue

Published transcript · Full recording available. Publication updated 2026-11-15T21:30:21.595Z.
Transcript version v1-5b5f744fe9c3638a469e · publication revision 1. Generated by AI; no listener-verified accuracy score is available.

Dotted spans marked ? have an unclear speaker. They remain unattributed even when shown inside a surrounding turn.

Copy or download
ReadableGrouped by speaker and paragraph with timestamps. Stored words unchanged.
As storedOne line per stored segment with its original speaker ID and start time. Exactly the stored words.
Official issuer source ↗Company overview ↗
TRANSCRIPT FEEDBACK

Report a passage

Your report is queued privately for review. It does not change this transcript automatically. Please avoid personal information.